Find A Doctor Find A Service Make An Appointment Talk To A Doctor

banner
increase text size decrease text size printer friendly



  • Prostate Cancer

  • Prostate Cancer

    Title(s):
    RTOG 0815. A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Prostate Cancer

    Title(s):
    RTOG 0924. Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

    Investigator(s):
    Mitchel Fromm, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Prostate Cancer

    Title(s):
    CTSU A031201. A Phase III Trial of Enzalutamide (NSC#766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  • Prostate Cancer

    Title(s):
    15027. A Pilot Study of Dexamethasone Therapy Prior to Rechallenge with Enzalutamide in Men with Metastatic Castration-Resistant Prostate Cancer Dex EXTends Enza Response (The DEXTER Trial)

    Investigator(s):
    Esther Rehmus, MD

    Contact Information:
    McDowell Cancer Research at 330-344-6348

  •  




    Akron General Medical Center • 1 Akron General Avenue (Formerly 400 Wabash Avenue) • Akron, OH 44307 • 330-344-6000 • 1-800-221-4601    © 2016 Akron General Health System
    Find Us on Facebook button


    This website is certified by Health On the Net Foundation. Click to verify.

      This site complies with the HONcode standard for trustworthy health information: verify here.